April 2026
The global mRNA therapeutics CDMO market size is estimated to hit around USD 14.63 billion by 2035 from USD 5.09 billion in 2025, with a CAGR of 11.14%.
June 2026
The global peptide therapeutics CDMO market is growing as pharma and biotech companies outsource complex peptide drug development and manufacturing.
June 2026
The mRNA vaccines and therapeutics market size reached USD 116.88 billion in 2025 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
May 2026
The mRNA therapeutics market size was valued at USD 20.83 billion in 2025 and is expected to hit around USD 45.40 billion by 2035, growing at a CAGR of 8.1%.
July 2025
The U.S. mRNA therapeutics market size was estimated at USD 5.48 billion in 2025 and is projected to hit USD 12.70 billion by 2036, with a notable CAGR of 8.77%
August 2025
The global gene editing & mRNA tool kits market is driving advancements in gene therapy, synthetic biology, and molecular diagnostics worldwide
June 2026
The global plasma therapeutics market size is estimated to hit around USD 52.26 billion by 2035 increasing from USD 28.35 billion in 2025, with a CAGR of 6.31%.
June 2026
The global cancer therapeutics and biotherapeutics market size was valued at USD 210.73 billion in 2025 and is expected to hit around USD 475.26 billion by 2035, growing at a CAGR of 8.47%.
June 2026
The global natural killer (NK) cell therapeutics market size was evaluated at USD 477.10 million in 2025 and is predicted to hit around USD 12,316.96 million by 2035, growing at a CAGR of 38.42%.
June 2026
The global bacterial therapeutics market is growing as microbiome-based treatments gain traction in healthcare and biotechnology.
June 2026
The global checkpoint inhibitor biologics CDMO market is growing as demand rises for outsourced biologics development and scalable immuno-oncology manufacturing.
June 2026
The global psychedelic therapeutics market size is estimated to hit around USD 12.40 billion by 2035 increasing from USD 2.94 billion in 2025, with a CAGR of 15.48%.
June 2026
The global pharmaceutical CDMO for formulations market size is accounted to hit around USD 103.33 billion by 2035, increasing from USD 48.85 billion in 2025, with a CAGR of 7.78%.
June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 5.68 billion in 2025 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
June 2026
The global exosome therapeutics market size is evaluated at USD 928.93 thousand in 2025 and is predicted to hit around USD 4,564.32 thousand by 2035, with a CAGR of 17.26%.
June 2026
The global amyloidosis therapeutics market size was valued at USD 3.18 billion in 2025 and is expected to hit around 6.92 billion by 2035, growing at a CAGR of 8.09% from 2026 to 2035.
June 2026
The global AI-integrated CDMO process optimization market is growing as contract manufacturers adopt AI to streamline drug development and manufacturing workflows.
June 2026
The global Duchenne muscular dystrophy therapeutics market size was evaluated at USD 6.80 billion in 2025 and is predicted to hit around USD 26.88 billion by 2035, growing at a CAGR of 14.80%.
June 2026
The global breast cancer therapeutics market size was valued at USD 33.45 billion in 2025 and is expected to hit around USD 66.72 billion by 2035, at a CAGR of 7.27%.
June 2026
The global targeted therapeutics market size was estimated at USD 85.75 billion in 2025 and is projected to hit around USD 163.91 billion by 2035 with a CAGR of 6.69%.
June 2026
The global narcolepsy therapeutics market size is accounted at USD 4.12 billion in 2025 and is expected to hit around USD 9.31 billion by 2035 with a CAGR of 8.49%.
May 2026
The global melanoma therapeutics market size accounted for USD 7.39 billion in 2025 and is expected to hit around USD 19.61 billion by 2035, at a CAGR of 10.25%.
May 2026
The global microbiome therapeutics market size is evaluated at USD 250.06 million in 2025 and is predicted to hit around USD 4,120.15 million by 2035, with a CAGR of 32.34%.
May 2026
The global multiple sclerosis therapeutics market size was evaluated at USD 34.80 billion in 2025 and is predicted to hit around USD 66.80 billion by 2035, growing at a CAGR of 6.90%.
May 2026
The global peptide therapeutics contract API manufacturing market size is estimated to hit around USD 9.02 billion by 2035 from USD 3.84 billion in 2025, at a CAGR of 9.02%.
May 2026
Europe Pharmaceutical CDMO market size is projected to hit around USD 94.94 billion by 2035, rising from USD 45.68 billion in 2025, growing at a CAGR of 7.59%.
May 2026
The global cancer therapeutics market size was evaluated at USD 212.58 billion in 2025 and is expected to surpass around USD 501.07 billion by 2034 with a CAGR of 8.95%.
May 2026
The global amyloid beta therapeutics market size was evaluated at USD 5.20 billion in 2025 and is predicted to hit around USD 26.50 billion by 2035, growing at a CAGR of 17.80%.
May 2026
The peptide therapeutics market size is expected to increase from USD 52.59 billion in 2025 to nearly USD 87.21 billion by 2035 with a notable CAGR of 5.19%.
May 2026
The global tau protein targeting therapeutics market size was evaluated at USD 1,100.00 million in 2025 and is predicted to hit around USD 6,534.16 million by 2035, growing at a CAGR of 19.50%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com